The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Luckily for you, we at StockStory have no conflicts of interest - our sole job is to help you find genuinely promising companies. That said, here are three stocks likely to meet or exceed Wall Street’s lofty expectations.
Doximity (DOCS)
Consensus Price Target: $25.42 (24.2% implied return)
With over 80% of U.S. physicians as members of its digital community, Doximity (NYSE: DOCS) operates a digital platform that enables physicians and other healthcare professionals to collaborate, stay current with medical news, manage their careers, and conduct virtual patient visits.
Why Do We Like DOCS?
- Software offerings and brand resonate with consumers, as seen in its above-market 25.5% annual sales growth over the last five years
- Superior software functionality and low servicing costs result in a best-in-class gross margin of 89.1%
- Software platform has product-market fit given the rapid recovery of its customer acquisition costs
Doximity is trading at $20.47 per share, or 6.1x forward price-to-sales. Is now the right time to buy? Find out in our full research report, it’s free.
Crane NXT (CXT)
Consensus Price Target: $66.83 (36% implied return)
Born from a corporate transformation completed in 2023, Crane NXT (NYSE: CXT) provides specialized technology solutions for payment processing, banknote security, and authentication systems for financial institutions and businesses.
Why Could CXT Be a Winner?
- Average backlog growth of 15.3% over the past two years shows it has a steady sales pipeline that will drive future orders
- $1.71 billion in revenue allows it to spread its fixed costs across a wider base
- Market share is on track to rise over the next 12 months as its 16.3% projected revenue growth implies demand will accelerate from its two-year trend
Crane NXT’s stock price of $49.13 implies a valuation ratio of 10.9x forward P/E. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free.
Charles Schwab (SCHW)
Consensus Price Target: $115.85 (28.2% implied return)
Founded in 1971 as a disruptive force challenging Wall Street's high fees and limited access, Charles Schwab (NYSE: SCHW) is a wealth management and brokerage firm that provides investment services, banking, and financial advice to individual investors and independent advisors.
Why Will SCHW Outperform?
- Annual revenue growth of 15.9% over the past two years was outstanding, reflecting market share gains this cycle
- Performance over the past two years was turbocharged by share buybacks, which enabled its earnings per share to grow faster than its revenue
- Industry-leading 14.9% return on equity demonstrates management’s skill in finding high-return investments
At $90.35 per share, Charles Schwab trades at 14.1x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
